Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis

The prognostic significance of histopathologic (sub)classes in the current classification of lupus nephritis (LN) is controversial. We analyzed clinical and histopathologic predictors of renal outcome in LN outside the framework of the classification. Variables (50 histopathologic and ten clinical)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical journal of the American Society of Nephrology 2017-05, Vol.12 (5), p.734-743
Hauptverfasser: Rijnink, Emilie C, Teng, Y K Onno, Wilhelmus, Suzanne, Almekinders, Mathilde, Wolterbeek, Ron, Cransberg, Karlien, Bruijn, Jan A, Bajema, Ingeborg M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 743
container_issue 5
container_start_page 734
container_title Clinical journal of the American Society of Nephrology
container_volume 12
creator Rijnink, Emilie C
Teng, Y K Onno
Wilhelmus, Suzanne
Almekinders, Mathilde
Wolterbeek, Ron
Cransberg, Karlien
Bruijn, Jan A
Bajema, Ingeborg M
description The prognostic significance of histopathologic (sub)classes in the current classification of lupus nephritis (LN) is controversial. We analyzed clinical and histopathologic predictors of renal outcome in LN outside the framework of the classification. Variables (50 histopathologic and ten clinical) were tested in mixed, linear, and Cox regression models for their association with renal flare, ESRD, and eGFR during follow-up (1, 5, and 10 years) in 105 patients with LN who underwent biopsy from 1987 to 2011. The Cockcroft-Gault (normalized to a body surface area of 1.73 m ) and Schwartz formulas were used to calculate eGFR for adults and children, respectively. During median follow-up of 9.9 years (25th-75th percentile, 5.9-13.8), 47 patients experienced a renal flare and 21 progressed to ESRD. Renal flare was predicted by fibrinoid necrosis (hazard ratio [HR], 1.04 per %; 95% confidence interval [95% CI], 1.00 to 1.07) and nonwhite race (HR, 2.23; 95% CI, 1.23 to 4.04). ESRD was predicted by fibrinoid necrosis (HR, 1.08 per %; 95% CI, 1.02 to 1.13), fibrous crescents (HR, 1.09 per %; 95% CI, 1.02 to 1.17), interstitial fibrosis/tubular atrophy (IF/TA) ≥25% (HR, 3.89; 95% CI, 1.25 to 12.14), eGFR at baseline (HR, 0.98 per ml/min per 1.73 m ; 95% CI, 0.97 to 1.00), and nonwhite race (HR, 7.16; 95% CI, 2.34 to 21.91). A higher mean eGFR during follow-up was associated with normal glomeruli (+0.2 ml/min per 1.73 m per %; 95% CI, 0.1 to 0.4). Like ESRD, a lower eGFR during follow-up was associated with fibrous crescents, IF/TA≥25%, and nonwhite race, as well as with cellular/fibrocellular crescents (-0.4 ml/min per 1.73 m per %; 95% CI, -0.6 to -0.2) and age (-0.8 ml/min per 1.73 m per year; 95% CI, -1.2 to -0.4). The LN classification should include an index of evidence-based prognosticators. Awaiting validation of a formal index, we suggest that at least fibrinoid necrosis, fibrous crescents, and IF/TA warrant explicit independent scoring to assess the risk of progressive renal dysfunction in conjunction with clinical findings.
doi_str_mv 10.2215/CJN.10601016
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5477219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1896040007</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-16c45a755d4169f76a610116b63a28dc774992e836b8b6e4ce107bd6bb2158773</originalsourceid><addsrcrecordid>eNpVUctOwzAQtBCIlseNM_KRAyl24kdyQaoioKCqlRBInLAcx22M0jjYDoi_J1UfgtOudmdndncAuMBoFMeY3uRPsxFGDGGE2QEYYkpplCH6drjPCR6AE-8_ECIkiekxGMQp4UmC-RC857VpjJI1lE0JJ8YH28pQ2doujYJ5JZ1UQbu-bpSHY--tMjLoEn6bUMFn3fST8y4ou9IemgZOu7bzcKbbyplg_Bk4Wsja6_NtPAWv93cv-SSazh8e8_E0UklKQoSZIlRySkuCWbbgTLL-HMwKlsg4LRXnJMtinSasSAumidIY8aJkRdF_IOU8OQW3G962K1a6VLoJTtaidWYl3Y-w0oj_ncZUYmm_BCWcxzjrCa62BM5-dtoHsTJe6bqWjbadFzjNGCIIobXW9QaqnPXe6cVeBiOxtkT0loidJT388u9qe_DOg-QXAnCH9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1896040007</pqid></control><display><type>article</type><title>Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Rijnink, Emilie C ; Teng, Y K Onno ; Wilhelmus, Suzanne ; Almekinders, Mathilde ; Wolterbeek, Ron ; Cransberg, Karlien ; Bruijn, Jan A ; Bajema, Ingeborg M</creator><creatorcontrib>Rijnink, Emilie C ; Teng, Y K Onno ; Wilhelmus, Suzanne ; Almekinders, Mathilde ; Wolterbeek, Ron ; Cransberg, Karlien ; Bruijn, Jan A ; Bajema, Ingeborg M</creatorcontrib><description>The prognostic significance of histopathologic (sub)classes in the current classification of lupus nephritis (LN) is controversial. We analyzed clinical and histopathologic predictors of renal outcome in LN outside the framework of the classification. Variables (50 histopathologic and ten clinical) were tested in mixed, linear, and Cox regression models for their association with renal flare, ESRD, and eGFR during follow-up (1, 5, and 10 years) in 105 patients with LN who underwent biopsy from 1987 to 2011. The Cockcroft-Gault (normalized to a body surface area of 1.73 m ) and Schwartz formulas were used to calculate eGFR for adults and children, respectively. During median follow-up of 9.9 years (25th-75th percentile, 5.9-13.8), 47 patients experienced a renal flare and 21 progressed to ESRD. Renal flare was predicted by fibrinoid necrosis (hazard ratio [HR], 1.04 per %; 95% confidence interval [95% CI], 1.00 to 1.07) and nonwhite race (HR, 2.23; 95% CI, 1.23 to 4.04). ESRD was predicted by fibrinoid necrosis (HR, 1.08 per %; 95% CI, 1.02 to 1.13), fibrous crescents (HR, 1.09 per %; 95% CI, 1.02 to 1.17), interstitial fibrosis/tubular atrophy (IF/TA) ≥25% (HR, 3.89; 95% CI, 1.25 to 12.14), eGFR at baseline (HR, 0.98 per ml/min per 1.73 m ; 95% CI, 0.97 to 1.00), and nonwhite race (HR, 7.16; 95% CI, 2.34 to 21.91). A higher mean eGFR during follow-up was associated with normal glomeruli (+0.2 ml/min per 1.73 m per %; 95% CI, 0.1 to 0.4). Like ESRD, a lower eGFR during follow-up was associated with fibrous crescents, IF/TA≥25%, and nonwhite race, as well as with cellular/fibrocellular crescents (-0.4 ml/min per 1.73 m per %; 95% CI, -0.6 to -0.2) and age (-0.8 ml/min per 1.73 m per year; 95% CI, -1.2 to -0.4). The LN classification should include an index of evidence-based prognosticators. Awaiting validation of a formal index, we suggest that at least fibrinoid necrosis, fibrous crescents, and IF/TA warrant explicit independent scoring to assess the risk of progressive renal dysfunction in conjunction with clinical findings.</description><identifier>ISSN: 1555-9041</identifier><identifier>EISSN: 1555-905X</identifier><identifier>DOI: 10.2215/CJN.10601016</identifier><identifier>PMID: 28473317</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Adolescent ; Adult ; Biopsy ; Disease Progression ; Female ; Fibrosis ; Glomerular Filtration Rate ; Humans ; Immunosuppressive Agents - therapeutic use ; Kidney - drug effects ; Kidney - pathology ; Kidney - physiopathology ; Kidney Failure, Chronic - etiology ; Kidney Failure, Chronic - pathology ; Kidney Failure, Chronic - physiopathology ; Kidney Failure, Chronic - therapy ; Linear Models ; Lupus Nephritis - complications ; Lupus Nephritis - pathology ; Lupus Nephritis - physiopathology ; Lupus Nephritis - therapy ; Male ; Multivariate Analysis ; Necrosis ; Original ; Predictive Value of Tests ; Proportional Hazards Models ; Renal Dialysis ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Young Adult</subject><ispartof>Clinical journal of the American Society of Nephrology, 2017-05, Vol.12 (5), p.734-743</ispartof><rights>Copyright © 2017 by the American Society of Nephrology.</rights><rights>Copyright © 2017 by the American Society of Nephrology 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-16c45a755d4169f76a610116b63a28dc774992e836b8b6e4ce107bd6bb2158773</citedby><cites>FETCH-LOGICAL-c384t-16c45a755d4169f76a610116b63a28dc774992e836b8b6e4ce107bd6bb2158773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477219/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477219/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28473317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rijnink, Emilie C</creatorcontrib><creatorcontrib>Teng, Y K Onno</creatorcontrib><creatorcontrib>Wilhelmus, Suzanne</creatorcontrib><creatorcontrib>Almekinders, Mathilde</creatorcontrib><creatorcontrib>Wolterbeek, Ron</creatorcontrib><creatorcontrib>Cransberg, Karlien</creatorcontrib><creatorcontrib>Bruijn, Jan A</creatorcontrib><creatorcontrib>Bajema, Ingeborg M</creatorcontrib><title>Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis</title><title>Clinical journal of the American Society of Nephrology</title><addtitle>Clin J Am Soc Nephrol</addtitle><description>The prognostic significance of histopathologic (sub)classes in the current classification of lupus nephritis (LN) is controversial. We analyzed clinical and histopathologic predictors of renal outcome in LN outside the framework of the classification. Variables (50 histopathologic and ten clinical) were tested in mixed, linear, and Cox regression models for their association with renal flare, ESRD, and eGFR during follow-up (1, 5, and 10 years) in 105 patients with LN who underwent biopsy from 1987 to 2011. The Cockcroft-Gault (normalized to a body surface area of 1.73 m ) and Schwartz formulas were used to calculate eGFR for adults and children, respectively. During median follow-up of 9.9 years (25th-75th percentile, 5.9-13.8), 47 patients experienced a renal flare and 21 progressed to ESRD. Renal flare was predicted by fibrinoid necrosis (hazard ratio [HR], 1.04 per %; 95% confidence interval [95% CI], 1.00 to 1.07) and nonwhite race (HR, 2.23; 95% CI, 1.23 to 4.04). ESRD was predicted by fibrinoid necrosis (HR, 1.08 per %; 95% CI, 1.02 to 1.13), fibrous crescents (HR, 1.09 per %; 95% CI, 1.02 to 1.17), interstitial fibrosis/tubular atrophy (IF/TA) ≥25% (HR, 3.89; 95% CI, 1.25 to 12.14), eGFR at baseline (HR, 0.98 per ml/min per 1.73 m ; 95% CI, 0.97 to 1.00), and nonwhite race (HR, 7.16; 95% CI, 2.34 to 21.91). A higher mean eGFR during follow-up was associated with normal glomeruli (+0.2 ml/min per 1.73 m per %; 95% CI, 0.1 to 0.4). Like ESRD, a lower eGFR during follow-up was associated with fibrous crescents, IF/TA≥25%, and nonwhite race, as well as with cellular/fibrocellular crescents (-0.4 ml/min per 1.73 m per %; 95% CI, -0.6 to -0.2) and age (-0.8 ml/min per 1.73 m per year; 95% CI, -1.2 to -0.4). The LN classification should include an index of evidence-based prognosticators. Awaiting validation of a formal index, we suggest that at least fibrinoid necrosis, fibrous crescents, and IF/TA warrant explicit independent scoring to assess the risk of progressive renal dysfunction in conjunction with clinical findings.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biopsy</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney - drug effects</subject><subject>Kidney - pathology</subject><subject>Kidney - physiopathology</subject><subject>Kidney Failure, Chronic - etiology</subject><subject>Kidney Failure, Chronic - pathology</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Linear Models</subject><subject>Lupus Nephritis - complications</subject><subject>Lupus Nephritis - pathology</subject><subject>Lupus Nephritis - physiopathology</subject><subject>Lupus Nephritis - therapy</subject><subject>Male</subject><subject>Multivariate Analysis</subject><subject>Necrosis</subject><subject>Original</subject><subject>Predictive Value of Tests</subject><subject>Proportional Hazards Models</subject><subject>Renal Dialysis</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Young Adult</subject><issn>1555-9041</issn><issn>1555-905X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUctOwzAQtBCIlseNM_KRAyl24kdyQaoioKCqlRBInLAcx22M0jjYDoi_J1UfgtOudmdndncAuMBoFMeY3uRPsxFGDGGE2QEYYkpplCH6drjPCR6AE-8_ECIkiekxGMQp4UmC-RC857VpjJI1lE0JJ8YH28pQ2doujYJ5JZ1UQbu-bpSHY--tMjLoEn6bUMFn3fST8y4ou9IemgZOu7bzcKbbyplg_Bk4Wsja6_NtPAWv93cv-SSazh8e8_E0UklKQoSZIlRySkuCWbbgTLL-HMwKlsg4LRXnJMtinSasSAumidIY8aJkRdF_IOU8OQW3G962K1a6VLoJTtaidWYl3Y-w0oj_ncZUYmm_BCWcxzjrCa62BM5-dtoHsTJe6bqWjbadFzjNGCIIobXW9QaqnPXe6cVeBiOxtkT0loidJT388u9qe_DOg-QXAnCH9A</recordid><startdate>20170508</startdate><enddate>20170508</enddate><creator>Rijnink, Emilie C</creator><creator>Teng, Y K Onno</creator><creator>Wilhelmus, Suzanne</creator><creator>Almekinders, Mathilde</creator><creator>Wolterbeek, Ron</creator><creator>Cransberg, Karlien</creator><creator>Bruijn, Jan A</creator><creator>Bajema, Ingeborg M</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170508</creationdate><title>Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis</title><author>Rijnink, Emilie C ; Teng, Y K Onno ; Wilhelmus, Suzanne ; Almekinders, Mathilde ; Wolterbeek, Ron ; Cransberg, Karlien ; Bruijn, Jan A ; Bajema, Ingeborg M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-16c45a755d4169f76a610116b63a28dc774992e836b8b6e4ce107bd6bb2158773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biopsy</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney - drug effects</topic><topic>Kidney - pathology</topic><topic>Kidney - physiopathology</topic><topic>Kidney Failure, Chronic - etiology</topic><topic>Kidney Failure, Chronic - pathology</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Linear Models</topic><topic>Lupus Nephritis - complications</topic><topic>Lupus Nephritis - pathology</topic><topic>Lupus Nephritis - physiopathology</topic><topic>Lupus Nephritis - therapy</topic><topic>Male</topic><topic>Multivariate Analysis</topic><topic>Necrosis</topic><topic>Original</topic><topic>Predictive Value of Tests</topic><topic>Proportional Hazards Models</topic><topic>Renal Dialysis</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rijnink, Emilie C</creatorcontrib><creatorcontrib>Teng, Y K Onno</creatorcontrib><creatorcontrib>Wilhelmus, Suzanne</creatorcontrib><creatorcontrib>Almekinders, Mathilde</creatorcontrib><creatorcontrib>Wolterbeek, Ron</creatorcontrib><creatorcontrib>Cransberg, Karlien</creatorcontrib><creatorcontrib>Bruijn, Jan A</creatorcontrib><creatorcontrib>Bajema, Ingeborg M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rijnink, Emilie C</au><au>Teng, Y K Onno</au><au>Wilhelmus, Suzanne</au><au>Almekinders, Mathilde</au><au>Wolterbeek, Ron</au><au>Cransberg, Karlien</au><au>Bruijn, Jan A</au><au>Bajema, Ingeborg M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis</atitle><jtitle>Clinical journal of the American Society of Nephrology</jtitle><addtitle>Clin J Am Soc Nephrol</addtitle><date>2017-05-08</date><risdate>2017</risdate><volume>12</volume><issue>5</issue><spage>734</spage><epage>743</epage><pages>734-743</pages><issn>1555-9041</issn><eissn>1555-905X</eissn><abstract>The prognostic significance of histopathologic (sub)classes in the current classification of lupus nephritis (LN) is controversial. We analyzed clinical and histopathologic predictors of renal outcome in LN outside the framework of the classification. Variables (50 histopathologic and ten clinical) were tested in mixed, linear, and Cox regression models for their association with renal flare, ESRD, and eGFR during follow-up (1, 5, and 10 years) in 105 patients with LN who underwent biopsy from 1987 to 2011. The Cockcroft-Gault (normalized to a body surface area of 1.73 m ) and Schwartz formulas were used to calculate eGFR for adults and children, respectively. During median follow-up of 9.9 years (25th-75th percentile, 5.9-13.8), 47 patients experienced a renal flare and 21 progressed to ESRD. Renal flare was predicted by fibrinoid necrosis (hazard ratio [HR], 1.04 per %; 95% confidence interval [95% CI], 1.00 to 1.07) and nonwhite race (HR, 2.23; 95% CI, 1.23 to 4.04). ESRD was predicted by fibrinoid necrosis (HR, 1.08 per %; 95% CI, 1.02 to 1.13), fibrous crescents (HR, 1.09 per %; 95% CI, 1.02 to 1.17), interstitial fibrosis/tubular atrophy (IF/TA) ≥25% (HR, 3.89; 95% CI, 1.25 to 12.14), eGFR at baseline (HR, 0.98 per ml/min per 1.73 m ; 95% CI, 0.97 to 1.00), and nonwhite race (HR, 7.16; 95% CI, 2.34 to 21.91). A higher mean eGFR during follow-up was associated with normal glomeruli (+0.2 ml/min per 1.73 m per %; 95% CI, 0.1 to 0.4). Like ESRD, a lower eGFR during follow-up was associated with fibrous crescents, IF/TA≥25%, and nonwhite race, as well as with cellular/fibrocellular crescents (-0.4 ml/min per 1.73 m per %; 95% CI, -0.6 to -0.2) and age (-0.8 ml/min per 1.73 m per year; 95% CI, -1.2 to -0.4). The LN classification should include an index of evidence-based prognosticators. Awaiting validation of a formal index, we suggest that at least fibrinoid necrosis, fibrous crescents, and IF/TA warrant explicit independent scoring to assess the risk of progressive renal dysfunction in conjunction with clinical findings.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>28473317</pmid><doi>10.2215/CJN.10601016</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1555-9041
ispartof Clinical journal of the American Society of Nephrology, 2017-05, Vol.12 (5), p.734-743
issn 1555-9041
1555-905X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5477219
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Biopsy
Disease Progression
Female
Fibrosis
Glomerular Filtration Rate
Humans
Immunosuppressive Agents - therapeutic use
Kidney - drug effects
Kidney - pathology
Kidney - physiopathology
Kidney Failure, Chronic - etiology
Kidney Failure, Chronic - pathology
Kidney Failure, Chronic - physiopathology
Kidney Failure, Chronic - therapy
Linear Models
Lupus Nephritis - complications
Lupus Nephritis - pathology
Lupus Nephritis - physiopathology
Lupus Nephritis - therapy
Male
Multivariate Analysis
Necrosis
Original
Predictive Value of Tests
Proportional Hazards Models
Renal Dialysis
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Young Adult
title Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T22%3A55%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20Histopathologic%20Characteristics%20Associated%20with%20Renal%20Outcomes%20in%20Lupus%20Nephritis&rft.jtitle=Clinical%20journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Rijnink,%20Emilie%20C&rft.date=2017-05-08&rft.volume=12&rft.issue=5&rft.spage=734&rft.epage=743&rft.pages=734-743&rft.issn=1555-9041&rft.eissn=1555-905X&rft_id=info:doi/10.2215/CJN.10601016&rft_dat=%3Cproquest_pubme%3E1896040007%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1896040007&rft_id=info:pmid/28473317&rfr_iscdi=true